Robotic Gait Rehabilitation in Parkinson's Disease

Launched by INDIANA UNIVERSITY · Jan 20, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new type of rehabilitation called the G-EO System, designed to help people with Parkinson's disease improve their walking ability. The main goals of the study are to ensure that this system is safe to use and to see if it can really help improve mobility, daily functioning, and overall quality of life for participants.

To be eligible for this trial, participants need to be at least 18 years old and have a confirmed diagnosis of Parkinson's disease, specifically in stages 1 to 3. They should also be stable on their medications and have the approval of their doctor to participate in exercise. Participants will be randomly assigned to receive gait training using the G-EO System, and they can expect to engage in activities that may help them regain better control of their movement. This study is currently recruiting participants, and it aims to provide valuable insights into how this innovative rehabilitation tool can benefit those facing challenges with walking due to Parkinson's disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 18years
• • Confirmed diagnosis of Parkinson's Disease
• • Hoehn and Yahr stage 1 to 3
• • Stable course of disease-modifying therapy over the past 3 months
• • Mini Mental State Examination \> 24
• • Physician approval for exercise
• • Stable deep brain stimulation setting for the past year
• • Demonstrate a need for functional rehabilitation
• Exclusion Criteria:
• • • Severe dyskinesia or severe on-off phenomenon
• • Unstable medication regiment
• • Any co-morbidity that will interfere with walking
• • Conventional physical therapy or G-EO training within the past 6 months
• • Height \<1m or \>2m
• • Body weight \>150 kg
• • Contraindications to G-EO gait training (e.g., bone instability)